KATHLEEN DECORTE: Open Payments
NPI 1013466481 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 25 payments from 10 companies in 2025. Trend: 2023 $314 · 2024 $440 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $100 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $97 |
| GlaxoSmithKline, LLC. | 5 | $85 |
| GENZYME CORPORATION | 4 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: DUPIXENT, Wegovy, NEFFY, NUCALA, AIRSUPRA, VOQUEZNA, TEZSPIRE, Rhapsido.
Industry payments across IN — which companies pay providers there.
